Lyrica Generics Were Likely Delayed By A Pfizer Labeling Supplement

 
• By Derrick Gingery
stopping the Dominio effect
A labeling update approved just before patent expiry may have caused Lyrica generics to be cleared later than expected in the US • Source: Shutterstock

More from Regulation

More from Policy & Regulation